Reprogramming of liver cell fate by Hippo signaling
通过 Hippo 信号重新编程肝细胞命运
基本信息
- 批准号:8676791
- 负责人:
- 金额:$ 38.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-07-01 至 2018-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdultBiliaryBiological AssayBiologyCell TransplantationCellsCharacteristicsDataDevelopmentGene ExpressionGenesGenetic EpistasisGoalsGrowthHepaticHepatocyteIn SituIn VitroLaboratoriesLeadLiverLiver RegenerationLiver Stem CellLiver diseasesMaintenanceMammalsMediatingModelingMolecularMusNatural regenerationNatureNormal tissue morphologyOrganOrgan SizeOrgan TransplantationOrganoidsOutcome StudyPathway interactionsPatientsPopulationProcessPropertyProteinsReporterSignal TransductionSolidStagingStem cellsStructureTestingTherapeuticTransducersTransplantationWorkbasecell typecellular targetingchromatin immunoprecipitationempoweredin vivoinsightliver cell proliferationliver transplantationmatrigelmembernotch proteinnoveloval celloverexpressionprimitive cellprogenitorpublic health relevanceresearch studyresponserestorationself-renewaltissue culturetumorigenesis
项目摘要
DESCRIPTION (provided by applicant): Liver transplantation is the second most common form of solid organ transplant with more than a quarter of listed patients expiring prior to receiving an organ. Developing a means to either stimulate liver regeneration or cultivate liver cells under tissue culture conditions could potentially abrogate the need for transplantation. While several groups have attempted to cultivate liver stem cells in the laboratory, robust conditions that could fulfill the current transplantation needs have yet to be developed. Our laboratory has made two recent discoveries that may be useful for the expansion of liver stem cells. First, we have found that changes in Hippo signaling can reprogram mature hepatocytes into cells displaying characteristics of bipotential liver progenitor cells. Hippo signaling has ben previously described as a potent growth regulator, but this finding suggests this pathway also confers increased plasticity upon differentiated cells. Secondly, we have developed culture conditions in which manipulation of Hippo signaling allows for long-term growth and enormous expansion of liver progenitors and reprogrammed hepatocytes. We propose to investigate the nature of these findings in three parts: 1) Utilize a novel Hippo reporter mouse line to determine whether endogenous Hippo activity can mark the elusive liver progenitor cell in situ. 2) Elucidate whether reprogrammed-hepatocytes contain bona fide stem cells as tested functionally in vitro and in vivo; and 3) Investigate the downstream mechanisms by which YAP reprograms hepatocytes. Completion of this project would elucidate the nature of the liver progenitor/stem cell compartment; and explore the plasticity of liver cell fate as a strategy to develop transplantable cells for transplantation.
描述(由申请人提供):肝移植是固体器官移植的第二大最常见形式,在接收器官之前已有四分之一以上的患者到期。开发一种刺激肝脏再生或在组织培养条件下培养肝细胞的方法可能会消除移植的需求。尽管几个小组试图在实验室中培养肝脏干细胞,但可以满足当前移植需求的稳健条件尚未开发。我们的实验室已经进行了两个最近的发现,这些发现可能对肝干细胞的扩展有用。首先,我们发现河马信号的变化可以将成熟的肝细胞重新编程到显示两局肝脏祖细胞特征的细胞中。 Hippo信号传导先前已将BEN描述为有效的生长调节剂,但是这一发现表明该途径也使分化细胞上的可塑性增加。其次,我们开发了培养条件,在这种情况下,对河马信号的操纵允许长期生长和肝脏祖细胞的巨大扩张和重编程的肝细胞。我们建议在三个部分中研究这些发现的性质:1)利用新型的河马记者小鼠系来确定内源性河马活性是否可以标记难以捉摸的肝脏祖细胞原位。 2)阐明重编程的羊皮细胞是否包含真正在体外和体内测试的真正的干细胞; 3)研究YAP重编程肝细胞的下游机制。该项目的完成将阐明肝脏祖细胞/干细胞室的性质;并探索肝细胞命运的可塑性,作为发展可移植细胞进行移植的策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Fernando Camargo其他文献
Fernando Camargo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Fernando Camargo', 18)}}的其他基金
High resolution lineage tracing of developmental hematopoiesis
发育造血的高分辨率谱系追踪
- 批准号:
10585400 - 财政年份:2023
- 资助金额:
$ 38.23万 - 项目类别:
Generation of a temporal, spatial, and molecular map of in situ hematopoiesis
生成原位造血的时间、空间和分子图
- 批准号:
10415468 - 财政年份:2022
- 资助金额:
$ 38.23万 - 项目类别:
Image guided profiling of the native HSC niche
原生 HSC 利基的图像引导分析
- 批准号:
10018892 - 财政年份:2019
- 资助金额:
$ 38.23万 - 项目类别:
Image guided profiling of the native HSC niche
原生 HSC 利基的图像引导分析
- 批准号:
10212380 - 财政年份:2019
- 资助金额:
$ 38.23万 - 项目类别:
Project 1 - Molecular and cellular determinants of hematopoietic clonal expansion
项目 1 - 造血克隆扩增的分子和细胞决定因素
- 批准号:
10641540 - 财政年份:2017
- 资助金额:
$ 38.23万 - 项目类别:
Clonal analysis of hematopoietic stem and progenitor biology in situ
造血干细胞和祖细胞生物学原位克隆分析
- 批准号:
9225236 - 财政年份:2016
- 资助金额:
$ 38.23万 - 项目类别:
Clonal analysis of hematopoietic stem and progenitor biology in situ
造血干细胞和祖细胞生物学原位克隆分析
- 批准号:
9030319 - 财政年份:2016
- 资助金额:
$ 38.23万 - 项目类别:
相似国自然基金
PKR活化通过促进CD177+细胞形成胞外诱捕网致胆道闭锁的机制研究
- 批准号:82301954
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
食品级卡拉胶与肠道Bacteroides xylanisolvens互作调控FXR-FGF15通路而导致胆酸代谢异常的研究
- 批准号:32302232
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
双通道多窗口近红外二区成像在复杂肝外胆道结构显影和疾病诊断中的研究
- 批准号:
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:
胆道闭锁胆管细胞线粒体功能障碍后激活mtDNA/STING/NF-κB通路引发炎症反应
- 批准号:82300573
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
胆道闭锁中巨噬细胞活化肝动脉Notch3信号参与建立胆周缺氧微环境的作用
- 批准号:82301953
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Genetic regulation of ductular reaction in liver injury and regeneration
肝损伤和再生中导管反应的基因调控
- 批准号:
10595652 - 财政年份:2022
- 资助金额:
$ 38.23万 - 项目类别:
Establishing Sox9 as a regulator of intrahepatic bile duct development and regeneration
建立 Sox9 作为肝内胆管发育和再生的调节因子
- 批准号:
10537874 - 财政年份:2022
- 资助金额:
$ 38.23万 - 项目类别:
Novel gene discovery in disorders of the liver and biliary tree
肝脏和胆管系统疾病的新基因发现
- 批准号:
10552553 - 财政年份:2022
- 资助金额:
$ 38.23万 - 项目类别:
Augmented Notch signaling as a therapeutic approach for Alagille Syndrome
增强型 Notch 信号传导作为 Alagille 综合征的治疗方法
- 批准号:
10504974 - 财政年份:2022
- 资助金额:
$ 38.23万 - 项目类别:
Augmented Notch signaling as a therapeutic approach for Alagille Syndrome
增强型 Notch 信号传导作为 Alagille 综合征的治疗方法
- 批准号:
10672969 - 财政年份:2022
- 资助金额:
$ 38.23万 - 项目类别: